期刊文献+

HbA1c和hs-CRP与急性冠状动脉综合征预后的相关性研究 被引量:10

Evaluation on the correlation between prognosis of acute coronary syndrome and HbA1c and hs-CRP level
下载PDF
导出
摘要 目的探讨联合检测糖化血红蛋白(HbAlc)和hs-CRP对于急性冠状动脉综合征患者预后的预测价值。方法选取该院2009年8月至2011年8月收治的141例急性冠状动脉综合征患者。根据患者血中HbAlc和hs-CRP水平,将研究对象分为以下4组:高HbAlc高hs-CRP组,高HbAlc组,高hs-CRP组,低HbAlc低hs-CRP组(对照组)。随访至2012年8月,收集患者的临床资料并进行统计分析。结果与对照组相比,高HbAlc组患者在2年内、其他两组患者在整个随访时间内的累积生存率都有明显的下降(P〈0.05)。将HbAlC和hs-CRP作为协变量,对患者的生存时间进行Cox回归分析,得出回归方程为h(t,x)=h0(t)exp(0.092×HbAlc+0.610×hs-cRP)。上述方程经拟合优度检验,在α=0.05水平下,χ2=10.326,P〈0.01。HbAlc和hs-CRP的RR值分剐为1.971,95%CI(1.245~2.539),P〈0.05和3.398,95%CI(2.879-3.917),P〈0.05。该回归模型的灵敏度为75.4%,特异度为83.3%,Kappa值为0.446。结论联合检测HbAlc和hs-CRP对于急性冠状动脉综合征患者的预后具有中等程度的预测价值。 Objective To investigate the prognostic value of HbAlc and hs-CRP in patients with acute coronary syndrome. Methods A total of 141 patients diagnosed as acute coronary syndrome from August 2009 to August 2011 in this hospital were col- lected. According to the levels of HbAlc and hs-CRP, patients were divided into the following four groups., the high H bAlc and hs- CRP group,the high HbAlc group, the high hs-CRP group, the low HbAlc and hs-CRP group(control group). After receiving standard treatment and being discharged from hospital, all patients were followed up every two month until death or the end of the study. Clinical data from all patients were statistically analyzed. Results Compared with the control group, the cumulative survival of the high HbAlc group was much lower in 2 years(P〈0.05) and the difference between the two groups was not significant 2 years later(P〈0.05). However,the cumulative survival in high HbAlc and high hs-CRP group and the high hs-CRP group were significantly lower than the control group through the whole follow-up time. A Cox regression modal with HbAlc and hs-CRP as the covariates established and the formula was.. h(t, x) =h0 (t) exp (0. 092 × HbAlc + 0. 610× hs-CRP) ( χ2 = 10. 326, P〈0.01 ). The value of HbAlc and hs-CRP were associated with increased risk of mortality [RR 1. 971,95%CI(1. 245-2. 539), P〈0.05 and RR 3. 398,95 %CI(2. 879-3. 917) ,P〈0. 05, respectively]. The specificity and sensitivity of that modal was 75% and 83.6 %, respectively. The Kappa value was 0. 446. Conclusion The combined detection of HbAlc and hs-CRP level can predict the progno- sis of patients with acute coronary syndromes.
作者 余宏斌
出处 《重庆医学》 CAS CSCD 北大核心 2013年第28期3374-3376,共3页 Chongqing medicine
关键词 血红蛋白A 糖基化 高敏C反应蛋白 急性冠状动脉综合征 预后 hemoglobin A, glycosylated hs-CRP acute coronary syndrome prognosis
  • 相关文献

参考文献10

  • 1Cherneva ZV,Denchev SV, Gospodinova MV, et al. In-flammatory cytokines at admission — independent prog-nostic markers in patients with acute coronary syndromeand hyperglycaemia[J]. Acute Card Care, 2012, 14(1):13-19.
  • 2高润霖.急性心肌梗死诊断和治疗指南[J].中华心血管病杂志,2001,29(12):710-725. 被引量:4901
  • 3柯元南,陈纪林.不稳定性心绞痛和非ST段抬高心肌梗死诊断与治疗指南[J].中华心血管病杂志,2007,35(4):295-304. 被引量:2125
  • 4ten Brinke R,Dekker N,de Groot M, et al. LoweringHbAlc in type 2 diabetics results in reduced risk of coro-nary heart disease and all-cause mortality^J]. Prim CareDiabetes,2008,2(1) : 45-49.
  • 5张凤霞,严萍萍,朱雯,李勇,施海明.非糖尿病冠心病患者糖化血红蛋白的临床价值[J].中华实用诊断与治疗杂志,2009,23(3):217-219. 被引量:10
  • 6Liu Y,Yang YM, Zhu J,et al. Prognostic significance ofhemoglobin Ale level in patients hospitalized with coro-nary artery disease. A systematic review and meta-analy-sis[J]. Cardiovasc Diabetoi,2011,10(10) :98.
  • 7Timmer JR,Ottervanger JP.Bilo HJ,et al. Prognostic val-ue of admission glucose and glycosylated haemoglobin lev-els in acute coronary syndromes [J]. QJM,2006,99(4):237-243.
  • 8Rietzschel E,De Buyzere M. High-sensitive C-reactiveprotein : Universal prognostic and causative biomarker inheart disease. [J]. Biomark Med,2012,6(1) : 19-34.
  • 9Ridker PM. Inflammation in atherothrombosis : how to usehigh-sensitivity C-reactive protein (hs-CRP) in clinicalpractice[J]. Am Heart Hosp J,2004,2(4 Suppl 1) :S4-9.
  • 10Correia LC,Esteves JP. C-Reactive protein and outcomesin acute coronary syndromes : a systematic review and me-ta-analysis[J]. Arq Bras Cardiol,2011,97(1) :76-85.

二级参考文献27

  • 1中国心脏调查组,胡大一,潘长玉.中国住院冠心病患者糖代谢异常研究——中国心脏调查[J].中华内分泌代谢杂志,2006,22(1):7-10. 被引量:470
  • 2李小鹰.阿司匹林在动脉硬化性心血管疾病中的临床应用:中国专家共识(2005)[J].中华心血管病杂志,2006,34(3):281-284. 被引量:193
  • 3张会峰,赵志刚,秦贵军,汪艳芳,马书平.血清抵抗素与2型糖尿病及其大血管病变的相关性研究[J].实用诊断与治疗杂志,2006,20(5):316-318. 被引量:18
  • 4范泉,郭文怡,贾国良.冠心病患者糖化血红蛋白水平与冠状动脉病变的相关性[J].第四军医大学学报,2006,27(8):698-700. 被引量:76
  • 5Braunwald E, Antman EM, Beasley JW, et al. ACC/AHA 2002 guideline update for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction-summary article: a report of the American College of Cardiology/American Heart Association task force on practice guidelines(Committee on the Management of Patients With Unstable Angina). J Am Coll Cardiol,2002, 40(7) :1366-1374.
  • 6Bertrand ME, Simoons ML, Fox KA, et al. Management of acute coronary syndromes in patients presenting without persistent ST-segment elevation. Eur Heart J,2002,23 ( 23 ) : 1809 -1840.
  • 7Erhardt L, Herlitz J, Bossaert L, et al. Task force on the management of chest pain. Eur Heart J, 2002, 23 ( 15 ) : 1153-1176.
  • 8CAPRIE Steering Committee. A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). CAPRIE Steering Committee. Lancet, 1996, 348(9038) :1329-1339.
  • 9Yusuf S, Zhao F, Mehta SR, et al. Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation. N Engl J Med, 2001 , 345 ( 7 ) :494-502.
  • 10Mehta SR, Yusuf S, Peters RJ, et al. Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study. Lancet, 2001, 358(9281):527-533.

共引文献6942

同被引文献75

引证文献10

二级引证文献52

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部